Literature DB >> 19836156

Use of respiratory-correlated four-dimensional computed tomography to determine acceptable treatment margins for locally advanced pancreatic adenocarcinoma.

Seth D Goldstein1, Eric C Ford, Mario Duhon, Todd McNutt, John Wong, Joseph M Herman.   

Abstract

PURPOSE: Respiratory-induced excursions of locally advanced pancreatic adenocarcinoma could affect dose delivery. This study quantified tumor motion and evaluated standard treatment margins. METHODS AND MATERIALS: Respiratory-correlated four-dimensional computed tomography images were obtained on 30 patients with locally advanced pancreatic adenocarcinoma; 15 of whom underwent repeat scanning before cone-down treatment. Treatment planning software was used to contour the gross tumor volume (GTV), bilateral kidneys, and biliary stent. Excursions were calculated according to the centroid of the contoured volumes.
RESULTS: The mean +/- standard deviation GTV excursion in the superoinferior (SI) direction was 0.55 +/- 0.23 cm; an expansion of 1.0 cm adequately accounted for the GTV motion in 97% of locally advanced pancreatic adenocarcinoma patients. Motion GTVs were generated and resulted in a 25% average volume increase compared with the static GTV. Of the 30 patients, 17 had biliary stents. The mean SI stent excursion was 0.84 +/- 0.32 cm, significantly greater than the GTV motion. The xiphoid process moved an average of 0.35 +/- 0.12 cm, significantly less than the GTV. The mean SI motion of the left and right kidneys was 0.65 +/- 0.27 cm and 0.77 +/- 0.30 cm, respectively. At repeat scanning, no significant changes were seen in the mean GTV size (p = .8) or excursion (p = .3).
CONCLUSION: These data suggest that an asymmetric expansion of 1.0, 0.7, and 0.6 cm along the respective SI, anteroposterior, and medial-lateral directions is recommended if a respiratory-correlated four-dimensional computed tomography scan is not available to evaluate the tumor motion during treatment planning. Surrogates of tumor motion, such as biliary stents or external markers, should be used with caution. Copyright 2010 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2009        PMID: 19836156     DOI: 10.1016/j.ijrobp.2009.06.009

Source DB:  PubMed          Journal:  Int J Radiat Oncol Biol Phys        ISSN: 0360-3016            Impact factor:   7.038


  22 in total

1.  In vivo reproducibility of robotic probe placement for a novel ultrasound-guided radiation therapy system.

Authors:  Muyinatu A Lediju Bell; H Tutkun Sen; Iulian Iordachita; Peter Kazanzides; John Wong
Journal:  J Med Imaging (Bellingham)       Date:  2014-07-23

Review 2.  Motion management in gastrointestinal cancers.

Authors:  Hassan Abbas; Bryan Chang; Zhe Jay Chen
Journal:  J Gastrointest Oncol       Date:  2014-06

3.  A single reference measurement can predict liver tumor motion during respiration.

Authors:  Jakub Cvek; Lukas Knybel; Lukas Molenda; Bretislav Otahal; Tomas Jonszta; Daniel Czerny; David Feltl
Journal:  Rep Pract Oncol Radiother       Date:  2015-12-29

4.  Individually optimized stereotactic radiotherapy for pancreatic head tumors: A planning feasibility study.

Authors:  Milly Buwenge; Savino Cilla; Alessandra Guido; Lucia Giaccherini; Gabriella Macchia; Francesco Deodato; Silvia Cammelli; Francesco Cellini; Gian C Mattiucci; Vincenzo Valentini; Markus Stock; Alessio G Morganti
Journal:  Rep Pract Oncol Radiother       Date:  2016-09-28

Review 5.  Recent progress in pancreatic cancer.

Authors:  Christopher L Wolfgang; Joseph M Herman; Daniel A Laheru; Alison P Klein; Michael A Erdek; Elliot K Fishman; Ralph H Hruban
Journal:  CA Cancer J Clin       Date:  2013-07-15       Impact factor: 508.702

6.  Individually optimized contrast-enhanced 4D-CT for radiotherapy simulation in pancreatic ductal adenocarcinoma.

Authors:  Wookjin Choi; Ming Xue; Barton F Lane; Min Kyu Kang; Kruti Patel; William F Regine; Paul Klahr; Jiahui Wang; Shifeng Chen; Warren D'Souza; Wei Lu
Journal:  Med Phys       Date:  2016-10       Impact factor: 4.071

7.  Evaluation of predictive variables in locally advanced pancreatic adenocarcinoma patients receiving definitive chemoradiation.

Authors:  Sonali Rudra; Amol K Narang; Timothy M Pawlik; Hao Wang; Elizabeth M Jaffee; Lei Zheng; Dung T Le; David Cosgrove; Ralph H Hruban; Elliot K Fishman; Richard Tuli; Daniel A Laheru; Christopher L Wolfgang; Luis A Diaz; Joseph M Herman
Journal:  Pract Radiat Oncol       Date:  2012

8.  Comparative analysis of traditional and coiled fiducials implanted during EUS for pancreatic cancer patients receiving stereotactic body radiation therapy.

Authors:  Mouen A Khashab; Katherine J Kim; Erik J Tryggestad; Aaron T Wild; Teboh Roland; Vikesh K Singh; Anne Marie Lennon; Eun Ji Shin; Mark A Ziegler; Reem Z Sharaiha; Marcia Irene Canto; Joseph M Herman
Journal:  Gastrointest Endosc       Date:  2012-11       Impact factor: 9.427

9.  Daily breathing inconsistency in pancreas SBRT: a 4DCT study.

Authors:  Vikren Sarkar; Shane Lloyd; Adam Paxton; Long Huang; Fan-Chi Su; Randa Tao; Jonathan Tward; Hui Zhao; Bill Salter
Journal:  J Gastrointest Oncol       Date:  2018-12

10.  The analysis of respiration-induced pancreatic tumor motion based on reference measurement.

Authors:  Lukas Knybel; Jakub Cvek; Bretislav Otahal; Tomas Jonszta; Lukas Molenda; Daniel Czerny; Eva Skacelikova; Marian Rybar; Pavel Dvorak; David Feltl
Journal:  Radiat Oncol       Date:  2014-08-30       Impact factor: 3.481

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.